ICU Medical (ICUI) Tops Q4 EPS by 27c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus

Go back to ICU Medical (ICUI) Tops Q4 EPS by 27c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus

ICU Medical (ICUI) PT Lowered to $300 at Raymond James

March 1, 2019 7:33 AM EST

Raymond James analyst Jayson Bedford lowered the price target on ICU Medical (NASDAQ: ICUI) to $300.00 (from $315.00) while maintaining a Strong Buy rating.

Bedford said while Q4 was nicely above the mix was different than their thinking. The firm trimmed revenue estimates to... More